Inside the OASIS-1 Methodology: What Most Summaries Skip
A detailed breakdown of the OASIS-1 trial design, randomization, estimand framework, and statistical choices that produced the 15.1% weight-loss result for oral semaglutide 50 mg.
Trials Oasis 1
4 source-based articles maintained by the HealthRX.com Editorial Team.
4articles
1topic areas covered
May 25, 2026latest review
Trials Oasis 1 library
Showing 4 of 4 clinical reviews.
OASIS-1 Extension Data and What Happened After the Trial Ended
Deep dive into OASIS-1 trial follow-up and extension data for oral semaglutide 50 mg, covering weight regain patterns, durability of effect, and long-term safety signals beyond 68 weeks.
OASIS-1 Trial: A Plain-English Overview of What It Established
A deep-dive overview of the OASIS-1 trial, the first randomized controlled trial testing oral semaglutide 50 mg for weight loss, reporting 15.1% body weight reduction at 68 weeks.
What OASIS-1 Actually Changes in Clinical Practice
How the OASIS-1 trial of oral semaglutide 50 mg reshapes obesity treatment guidelines, prescribing patterns, and patient selection beyond the abstract results.
